CRO Services
As your Contract Research Organization, OXON helps plan and implement the generation of Real-World evidence for safety, market access/HEOR and drug development.
KNOW MORELate-phase studies
We help pharmaceutical, biotech and medical device companies to cost-effectively meet the requirements of late-phase clinical studies for better outcomes or greater value.
KNOW MORETherapeutic Areas
OXON offers proven experience and a large portfolio of studies in all major therapy areas, including orphan conditions, pregnancy, and risk minimization.
KNOW MOREReal World Evidence and Late-Phase Research
OXON has been selected as a preferred provider by several big pharma companies.
With strong links to EMA and world-renowned academics and institutions in Europe and Asia for studies and teaching, OXON offers proven experience and a large portfolio of studies in all major therapeutic areas.
OXON conducts:
• Primary data studies: prospective, registries, retrospective chart review, cross-sectional, surveys and pragmatic trials
• Secondary data studies: electronic records and registries
• Hybrid studies, including external controls for orphan medicines
• Synthesis research: systematic review and aggregate and IPD meta-analysis and landscaping
• Data analysis, modelling and simulation
We strive our best to support our clients in conducting cost-efficient observational studies worldwide
We pulled together
professionals and resources
to serve you better
READ MORELet us help design and conduct your optimal PASS or Outcomes observational study
OXON IS YOUR OBSERVATIONAL STUDIES SERVICE PROVIDER
OXON epidemiologists, statisticians, clinicians and project managers (ex-big pharma, ex-EMA), supported by consultancy from Stuart Pocock, Professor of Medical Statistics, London School of Hygiene & Tropical Medicine (´Pocock Stopping Rule´, sat on many data monitoring committees, extensive experience with EMA and FDA, classic textbook ´Clinical Trials´, >600 papers (100+ NEJM/Lancets)
REQUEST A MEETINGNewsroom
Read about us, our latest news and events
FREE LIVE DEBATE on RWE vs RCTs by leading Professors from Harvard, Oxford, London
FREE LIVE DEBATE “When can RWE be relied on to complement or replace evidence from RCTs to guide clinical decisions?” By leading Professors from Harvard, Oxford, London DATE: October 5,[…]
Read more
OXON RWE capabilities at ICPE Conference – 23-27 August 2023
OXON’s RWE solutions at the 39th International Conference on PharmacoEpidemiology, ICPE 2023. The Global Home for the Science of Real-World August 23-27, 2023. | Halifax Convention Centre | Halifax, Nova Scotia,[…]
Read more
OXON’s at the Global Clinical Trials Connect 2023 Conference
Nawab Qizilbash will be speaking at the Global Clinical Trial Connect 2023 Conference 10- 11 May 2023 Nawab Qizilbash, Senior Clinical Epidemiologist and Head of OXON will be participating at[…]
Read moreWe are a partner centre of the ENCePP scientific network, which is coordinated by the European Medicines Agency. We are dedicated to excellence in research by adhering to the ENCePP Guide on Methodological Standards and promoting scientific independence and transparency. We register studies in the EU PAS Register, a publicly accessible resource for the registration of pharmacoepidemiological and pharmacovigilance studies
